Dezapelisib Active Not Recruiting Phase 1 Trials for B-cell Malignancy Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01905813Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies